TY  - GEN 
AU  - Ritchlin, C. T.
AU  - Giles, J. T.
AU  - Ogdie, A.
AU  - Gómez-Reino Carnota, Juan Jesús
AU  - Helliwell, P.
AU  - Young, P.
AU  - Wang, C.
AU  - Wu, J.
AU  - Romero, A. B.
AU  - Woolcott, J.
AU  - Stockert, L.
PY  - 2020
SN  - 2578-5745
UR  - http://hdl.handle.net/20.500.11940/16551
AB  - OBJECTIVE: Metabolic syndrome (MetS) is a cluster of concurrent risk factors for cardiovascular disease and type 2 diabetes. This post hoc analysis explored key efficacy and safety endpoints in patients with psoriatic arthritis (PsA) and MetS treated...
TI  - Tofacitinib in Patients With Psoriatic Arthritis and Metabolic Syndrome: A Post hoc Analysis of Phase 3 Studies
DO  - 10.1002/acr2.11166
KW  - CHUS
VL  - 2
ER  -